triazolam has been researched along with Apnea in 2 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Apnea: A transient absence of spontaneous respiration.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Rocha, A | 1 |
Pinto, ACPN | 1 |
Pachito, DV | 1 |
Drager, LF | 1 |
Lorenzi-Filho, G | 1 |
Atallah, ÁN | 1 |
Attallah, A | 1 |
Seilanian, M | 1 |
Bavoux, F | 1 |
Choisy, H | 1 |
1 review available for triazolam and Apnea
Article | Year |
---|---|
Pharmacological treatment for central sleep apnoea in adults.
Topics: Acetazolamide; Adult; Aged; Apnea; Buspirone; Carbonic Anhydrase Inhibitors; Disorders of Excessive | 2023 |
1 other study available for triazolam and Apnea
Article | Year |
---|---|
[Psychotropics and pregnancy. Apropos of 2 case reports: the dose of triazolam].
Topics: Apnea; Female; Half-Life; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pr | 1989 |